Literature DB >> 106776

In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.

J W Biddle, C Thornsberry.   

Abstract

Randomly selected strains of beta-lactamase-negative and beta-lactamase-positive Neisseria gonorrhoeae were tested by an agar dilution method for susceptibility to rosamicin, josamycin, erythromycin, clindamycin, and penicillin G. Rosamicin was more active than erythromycin, which was more active than josamycin or clindamycin; the latter two were similar in their activity. The susceptibility to the macrolide antibiotics and clindamycin was independent of beta-lactamase production, but the penicillin minimal inhibitory concentrations were higher in the beta-lactamase-positive group because of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106776      PMCID: PMC352640          DOI: 10.1128/AAC.15.2.243

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  In vitro susceptibility studies with josamycin and erythromycin.

Authors:  L J Strausbaugh; J A Dilworth; J M Gwaltney; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

Review 2.  Antibiotic resistance in Neisseria gonorrhoeae.

Authors:  P F Sparling
Journal:  Med Clin North Am       Date:  1972-09       Impact factor: 5.456

3.  Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969.

Authors:  J E Martin; A Lester; E V Price; J D Schmale
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

4.  National gonorrhea therapy monitoring study: treatment results.

Authors:  R E Kaufman; R E Johnson; H W Jaffe; C Thornsberry; G H Reynolds; P J Wiesner
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

5.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03

6.  Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Observation of resistant strains of Neisseria gonorrhoeae.

Authors:  A Reyn; H Schmidt; M Trier; M W Bentzon
Journal:  Br J Vener Dis       Date:  1973-02

7.  Comparison of erythromycin base and estolate in gonococcal urethritis.

Authors:  S T Brown; H B Pedersen; K K Holmes
Journal:  JAMA       Date:  1977-09-26       Impact factor: 56.272

8.  In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

9.  Rosamicin--a new drug for the treatment of bacterial prostatitis.

Authors:  A Baumueller; U Hoyme; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

10.  Spectinomycin-resistant Neisseria gonorrhoeae.

Authors:  C Thornsberry; H Jaffee; S T Brown; T Edwards; J W Biddle; S E Thompson
Journal:  JAMA       Date:  1977-05-30       Impact factor: 56.272

View more
  8 in total

1.  Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

Authors:  R N Jones; A L Barry; P C Fuchs; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

2.  In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.

Authors:  W H Hall; B J Opfer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  Molecular and phenotypic characterization of penicillinase-producing Neisseria gonorrhoeae from Canadian sources.

Authors:  J R Dillon; P Duck; D Y Thomas
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

5.  In vitro susceptibility and cross-resistance of South African isolates of Neisseria gonorrhoeae to 14 antimicrobial agents.

Authors:  L D Liebowitz; R C Ballard; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

6.  Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.

Authors:  M T Labro; N Amit; C Babin-Chevaye; J Hakim
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

7.  In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.

Authors:  R N Jones; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

8.  Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.

Authors:  J A Robertson; J E Coppola; O R Heisler
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.